论文部分内容阅读
Non-nucleoside reverse transcriptase inhibitors (NNRTI's) are a major component of the current therapy for AIDS. However, in recent years, significant resistance has been generated against the marketed NNRTI's (nevirapine, delavirdine and efaviren